| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 24 |
| 1 | INFLIXIMAB | 13 |
| 2 | BEVACIZUMAB | 12 |
| 3 | PREDNISONE | 9 |
| 4 | ISOTRETINOIN | 8 |
| 5 | FUROSEMIDE | 6 |
| 6 | TIOTROPIUM BROMIDE | 6 |
| 7 | ALBUTEROL | 5 |
| 8 | ALBUTEROL SULFATE | 5 |
| 9 | ESOMEPRAZOLE | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NELFINAVIR MESYLATE | 2 | 0.0010 |
| 1 | TEMSIROLIMUS | 2 | 0.0004 |
| 2 | INOTUZUMAB OZOGAMICIN | 1 | 0.0003 |
| 3 | POLATUZUMAB VEDOTIN | 3 | 0.0003 |
| 4 | LAMIVUDINE AND ZIDOVUDINE | 2 | 0.0003 |
| 5 | FONDAPARINUX SODIUM | 2 | 0.0002 |
| 6 | DRONABINOL | 2 | 0.0002 |
| 7 | HYDROXOCOBALAMIN | 1 | 0.0002 |
| 8 | METHYLDOPA | 1 | 0.0002 |
| 9 | ISOTRETINOIN | 8 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD22-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 1 | Cannabinoid [EPC] | 2 | 0.0002 |
| 2 | Vitamin K [EPC] | 1 | 0.0001 |
| 3 | Chloride Channel Activator [EPC] | 1 | 0.0001 |
| 4 | GLP-2 Analog [EPC] | 1 | 0.0001 |
| 5 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 12 | 0.0001 |
| 6 | Integrin Receptor Antagonist [EPC] | 5 | 0.0001 |
| 7 | Topoisomerase Inhibitor [EPC] | 4 | 0.0001 |
| 8 | Nitroimidazole Antimicrobial [EPC] | 3 | 0.0000 |
| 9 | Bile Acid [EPC] | 1 | 0.0000 |